Cambridge Investment Research Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,658
| Closed | -$253K | – | 3142 |
|
|
2021
Q1 | $253K | Buy |
+2,658
| New | +$253K | ﹤0.01% | 2418 |
|
|
2020
Q4 | – | Sell |
-4,320
| Closed | -$257K | – | 2753 |
|
|
2020
Q3 | $257K | Buy |
+4,320
| New | +$257K | ﹤0.01% | 2053 |
|
|
2019
Q2 | – | Sell |
-2,712
| Closed | -$213K | – | 2288 |
|
|
2019
Q1 | $213K | Buy |
2,712
+261
| +11% | +$20.5K | ﹤0.01% | 2030 |
|
|
2018
Q4 | $207K | Sell |
2,451
-167
| -6% | -$14.1K | ﹤0.01% | 1895 |
|
|
2018
Q3 | $448K | Buy |
2,618
+167
| +7% | +$28.6K | ﹤0.01% | 1512 |
|
|
2018
Q2 | $317K | Sell |
2,451
-80
| -3% | -$10.3K | ﹤0.01% | 1692 |
|
|
2018
Q1 | $261K | Buy |
+2,531
| New | +$261K | ﹤0.01% | 1774 |
|
|
2016
Q4 | – | Sell |
-9,443
| Closed | -$601K | – | 1772 |
|
|
2016
Q3 | $601K | Buy |
9,443
+1,758
| +23% | +$112K | 0.01% | 935 |
|
|
2016
Q2 | $572K | Buy |
+7,685
| New | +$572K | 0.01% | 875 |
|
|
2014
Q1 | – | Sell |
-9,459
| Closed | -$310K | – | 1325 |
|
|
2013
Q4 | $310K | Buy |
9,459
+311
| +3% | +$10.2K | 0.01% | 869 |
|
|
2013
Q3 | $247K | Buy |
+9,148
| New | +$247K | 0.01% | 944 |
|